ArticleBMC medical genomics2026
Differentially expressed exosome miRNA profiles as putative prognostic biomarkers for profound sudden sensorineural hearing loss.
Article in BMC medical genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSudden sensorineural hearing loss (SSNHL) is an abrupt, often idiopathic hearing decline with uncertain prognosis and multifactorial pathophysiology. Among its subtypes, total deafness—also referred to as profound SSNHL—carries the worst and most unpredictable prognosis, highlighting an urgent need for reliable biomarkers, especially for prognostic biomarkers. Recent studies have emphasized the potential of exosome microRNAs (miRNAs) as both biomarkers and therapeutic targets in SSNHL, yet very few studies have focused on the profound type. This study aims to preliminarily identify the plasma-derived exosome miRNAs as candidate biomarkers, particularly possible prognostic indicators, in patients with profound SSNHL.
methodsOf 32 patients with profound SSNHL, six who achieved complete recovery and six age-matched patients with no improvement after two weeks of glucocorticoid therapy were selected for this retrospective study. Six age-matched healthy individuals with normal hearing served as controls. Pretreatment plasma samples were collected, exosomes purified and stored at -80℃. The exosome samples from 18 enrolled participants were subjected to RNA extraction and small RNA sequencing. Differentially expressed exosome miRNAs (DEEMs) were identified using the DESeq R package, with significance thresholds set at p < 0.05 and |log₂(fold change)| > 1. Predicted target mRNAs of DEEMs between the recovery and no improvement groups were analyzed for pathway enrichment using the Metascape database.
resultsWe identified 12 candidate DEEMs (10 downregulated and 2 upregulated) shared across all profound SSNHL groups compared to healthy controls, and 14 candidate DEEMs (6 downregulated and 8 upregulated) between the no improvement group and the recovery group. The six pronounced changed miRNAs out of those 14 were hsa-miR-320d, hsa-miR-146a-3p, hsa-miR-132-3p, hsa-miR-9-3p, hsa-miR-219b-5p, and hsa-miR-219a-2-3p. The target mRNAs of these top six miRNAs were mainly enriched in pathways of embryonic development, tube morphogenesis, cell division, synaptic transmission, STAT3 and TGF-β signaling, autophagy, cellular import, ketone response, and cellular responses to interleukin-1 and stress.
conclusionsBy exosomal miRNA profiling from patients of different treatment outcomes,, this exploratory study initially identified potential DEEMs that may serve as candidate biomarkers for profound SSNHL, although larger, independently replicated studies are required.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.